Max Chat
Company Analysis Tekla World Healthcare Fund
1. Summary
Advantages
- Price (10.69 $) is less than fair price (12.89 $)
- Dividends (11.81%) are higher than the sector average (3.23%).
- The company's current efficiency (ROE=0%) is higher than the sector average (ROE=-12.87%)
Disadvantages
- The stock's return over the last year (-18.83%) is lower than the sector average (4.6%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Tekla World Healthcare Fund | ΠΠ΅ΡΡΠ΅Π³Π°Π· | Index | |
|---|---|---|---|
| 7 days | 1.3% | 0% | -0.3% |
| 90 days | 5.6% | 2.2% | 17.4% |
| 1 year | -18.8% | 4.6% | 11.1% |
THW vs Sector: Tekla World Healthcare Fund has significantly underperformed the "ΠΠ΅ΡΡΠ΅Π³Π°Π·" sector by -23.43% over the past year.
THW vs Market: Tekla World Healthcare Fund has significantly underperformed the market by -29.96% over the past year.
Stable price: THW is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: THW with weekly volatility of -0.3621% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (10.69 $) is lower than the fair price (12.89 $).
Price significantly below the fair price: The current price (10.69 $) is 20.6% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (8.27).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (61.84).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.08) is higher than that of the sector as a whole (0.5139).
P/BV vs Market: The company's P/BV (1.08) is lower than that of the market as a whole (20.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (0.3388).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (15.97).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (3.4).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (18.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by 0% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (0%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (0%) is higher than that of the sector as a whole (-12.87%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (0%) is higher than that of the sector as a whole (-1.59%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.28%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.15%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 11.81% is higher than the average for the sector '3.23%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 11.81% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 11.81% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
